Journal
FATIGUE-BIOMEDICINE HEALTH AND BEHAVIOR
Volume 3, Issue 1, Pages 16-32Publisher
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/21641846.2014.978110
Keywords
myalgic encephalomyelitis; myalgic encephalomyelitis/chronic fatigue syndrome; chronic fatigue syndrome; reliability; DePaul Symptom Questionnaire
Categories
Funding
- National Institute of Allergy and Infectious Diseases [AI 49720, AI 055735]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105781, R01AI049720, R01AI055735] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Background: The DePaul Symptom Questionnaire (DSQ) was developed to provide a structured approach for collecting standardized symptomatology and health history information to allow researchers and clinicians to determine whether a patient meets the diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), myalgic encephalomyelitis ( ME), and/or chronic fatigue syndrome (CFS). Purpose: The purpose of this study was to examine the test-retest reliability of the DSQ. Methods: Test-retest reliability of the measure was examined with a sample of 26 adults self-identifying as having either ME/CFS, ME, and/or CFS and 25 adults who did not self-identify as having these illnesses and were otherwise healthy controls. Results: Overall, the majority of items on the DSQ exhibited good to excellent test-retest reliability, with Pearson's or kappa correlation coefficients that were 0.70 or higher. Conclusions: Thus, the present study suggests that the DSQ is a reliable diagnostic measure that can provide a standardized way of examining illness constructs and symptomatology among patients who identify as having ME/CFS, ME, and/or CFS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available